Doxorubicin hydrochloride
- Product NDC
- 16714-001
- 11-digit product format
- 167140001
- Labeler code
- 16714
- Product ID
- 16714-001_6756e484-6799-4a06-87b6-225583bd03a9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxorubicin hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Northstar RxLLC
- Application
- ANDA203622
- Marketing category
- ANDA
- Marketing start
- 2021-03-22
- Marketing end
- 0000-00-00
- Substance
- DOXORUBICIN HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-001-01 | 16714000101 | 1 VIAL, MULTI-DOSE in 1 CARTON (16714-001-01) > 100 mL in 1 VIAL, MULTI-DOSE | 2021-03-22 | 0000-00-00 | No | No | Current |